Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)
暂无分享,去创建一个
G. Arnaldi | Jacques Young | J. Bertherat | M. Fleseriu | B. Hatipoglu | B. Biller | M. Izquierdo | R. Pivonello | A. Pedroncelli | P. O'Connell